Innospec vs NewMarket
IOSP and NEU side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IOSP and NEU compare
NewMarket is the larger company, worth 3.3 times as much as Innospec ($6.4B against $1.9B).
Innospec grew revenue faster over the last twelve months (2.9% versus 0.89% for NewMarket).
Both pay dividends: Innospec yields 3.5% and NewMarket 1.7%.
NewMarket scores higher on the StockData Score (20 against 13 for Innospec), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IOSP | NEU |
|---|---|---|
| Size and price | ||
| Market cap | $1.9B | $6.4B |
| Share price | $78.01 | $697.76 |
| Change, 1 year | 5.3% | −11.0% |
| Change, 5 years | −6.2% | 105% |
| Beta (5Y) | 1.10 | 0.86 |
| Employees | 2,450 | 2,050 |
| StockData Score | ||
| Total score | 13 | 20 (better) |
| Valuation score | 3 | 4 (better) |
| Growth score | 1 | 1 |
| Performance score | 1 | 6 (better) |
| Health score | 6 (better) | 5 |
| Dividend score | 2 | 4 (better) |
| Valuation | ||
| P/E | – | 14.2× |
| P/S | 1.0× (better) | 2.3× |
| P/B | 1.4× (better) | 3.3× |
| EV/EBITDA | 9.9× (better) | 10.4× |
| P/FCF | – | 16.7× |
| PEG | – | 0.83 |
| FCF yield | – | 6.0% |
| Fair value | $92.08 | $864.14 |
| Margin of safety | 15.3% | 19.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 2.9% (better) | 0.89% |
| Revenue growth, 5Y average | 8.3% (better) | 6.3% |
| Net income growth (TTM) | – | 2.0% |
| EPS growth (TTM) | – | 4.2% |
| EPS growth, 5Y average | 32.1% (better) | 12.5% |
| Profitability | ||
| Gross margin | 27.5% | 31.7% (better) |
| Operating margin | 7.0% | 20.2% (better) |
| Net margin | – | 16.5% |
| FCF margin | – | 13.8% |
| Return on equity | – | 25.3% |
| Return on invested capital | 10.4% | 17.3% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.43 (better) |
| Net debt / EBITDA | – | 1.10 |
| Interest coverage | – | 15.8× |
| Current ratio | 2.78 (better) | 2.46 |
| Altman Z-score | 4.85 (better) | 4.44 |
| Piotroski F-score | – | 5 |
| Dividends and buybacks | ||
| Dividend yield | 3.5% (better) | 1.7% |
| Payout ratio | – | 24.4% |
| Years of dividend growth | 12 (better) | 7 |
| Dividend growth, 5Y average | 10.5% (better) | 8.2% |
| Buyback yield | 1.3% | 2.0% (better) |
| Shareholder yield | 4.8% (better) | 3.7% |
| Ownership | ||
| Held by institutions | 101% | 65.3% |
| Held by insiders | 1.6% | 17.4% |
| Insider net buying, 12 months | −$874K | $248K (better) |
| Short interest, % of float | 1.9% | 8.0% |
Go deeper
- IOSP stock overview
- IOSP income statement
- IOSP valuation and score
- NEU stock overview
- NEU income statement
- NEU valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.